FDA
approval
· 2017-02-16
FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
Summary
FDA approved a supplemental application for Fluticasone Propionate submitted by Padagis Israel Pharmaceuticals Ltd.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE)